ShortageWatch

Homatropine Methylbromide and Hydrocodone Bitartrate Syrup shortage

To Be Discontinued

Homatropine Methylbromide and Hydrocodone Bitartrate Syrup is currently listed as To Be Discontinued in the FDA Drug Shortage Database. Reported reason: Not specified.

Therapeutic category
Analgesia/Addiction
Dosage form
Syrup
Routes
ORAL
Last updated
09/11/2025

Strength variants

  • Not specified

Need sourcing help for Homatropine Methylbromide and Hydrocodone Bitartrate Syrup?

Get connected with licensed distributors and 503B compounders that can fulfill orders during active shortages. Verified suppliers, no spam.

Connect with a sourcing partner

Manufacturers reporting shortage

Reason for shortage

Not specified

ad slot 300x250

Related shortages in Analgesia/Addiction

Ketorolac Tromethamine Injection

Currently in Shortage
Category
Analgesia/Addiction
Reason
Not specified
Updated
04/06/2026

Ketorolac Tromethamine Injection

Currently in Shortage
Category
Analgesia/Addiction
Reason
Not specified
Updated
04/06/2026

Ketorolac Tromethamine Injection

Currently in Shortage
Category
Analgesia/Addiction
Reason
Not specified
Updated
04/06/2026

Remifentanil Hydrochloride Injection

Currently in Shortage
Category
Analgesia/Addiction
Reason
Not specified
Updated
04/03/2026

Remifentanil Hydrochloride Injection

Currently in Shortage
Category
Analgesia/Addiction
Reason
Not specified
Updated
04/03/2026

Remifentanil Hydrochloride Injection

Currently in Shortage
Category
Analgesia/Addiction
Reason
Not specified
Updated
04/03/2026

This information is not medical advice. Consult your pharmacist. Data is sourced from the FDA Drug Shortage Database and may not reflect real-time inventory at your facility. ShortageWatch is independent and not affiliated with the FDA.